Literature DB >> 27382041

Clinical characteristics, functional respiratory decline and follow-up in adult patients with primary ciliary dyskinesia.

Justine Frija-Masson1,2, Laurence Bassinet2, Isabelle Honoré1, Nadine Dufeu3, Bruno Housset2, André Coste4, Jean Francois Papon4,5, Estelle Escudier6,7, Pierre-Régis Burgel1, Bernard Maître2.   

Abstract

INTRODUCTION: Primary ciliary dyskinesia (PCD) is a genetic disease characterised by abnormalities in ciliary function, responsible for chronic pulmonary and sinonasal diseases. Adult clinical features and outcome are poorly described.
OBJECTIVES: To assess the clinical characteristics and disease progression in adults with PCD.
METHODS: Bicentric retrospective study, focusing on adults (≥18 years) with an asserted diagnosis of PCD based on the presence of bronchiectasis with typical ultrastructural defect of cilia and/or situs inversus (SI). Clinical symptoms, respiratory function, extent of bronchiectasis, microbiology and molecular analysis were assessed. Results are expressed as median (25th; 75th centile).
RESULTS: 78 patients were included with a median follow-up of 8.1 years. 91% of patients had respiratory symptoms and 95% had chronic rhinosinusitis. Half of ultrastructural defects concerned dynein arms. Respiratory function was significantly lower in women (FEV1=60% predicted (50; 76), vs 77% (62; 95), p=0.009) and in patients with chronic airway Pseudomonas aeruginosa (PA, n=21) infection (FEV1=60% (48; 71) vs 75% (55; 89), p=0.04). FEV1 was associated with gender (regression coefficient for men =13.8, p=0.009), chest CT score (r=-0.42, p<0.001) but not with age at diagnosis, SI or body mass index. FEV1 decline was -13.4 mL/year (-42.8; +11.9) and was greater in women (-29.3 mL/year, (-59.7; -11.9), vs -2.0 mL/year (-26.9; +25.4), p=0.002). Three patients had severe respiratory failure.
CONCLUSIONS: Alteration of respiratory function in adults with PCD is heterogeneous and usually moderate but appears more severe in women and in patients with chronic PA infection. Only 4% of patients develop chronic respiratory failure. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Bronchiectasis; Rare lung diseases

Mesh:

Year:  2016        PMID: 27382041     DOI: 10.1136/thoraxjnl-2015-207891

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  24 in total

1.  Successful conservative management of an anastomotic airway dehiscence at the left main bronchus following bilateral cadaveric lung transplantation.

Authors:  Ryo Miyata; Toyofumi F Chen-Yoshikawa; Masatsugu Hamaji; Fumiaki Gochi; Hideki Motoyama; Toshi Menju; Akihiro Aoyama; Toshihiko Sato; Makoto Sonobe; Hiroshi Date
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-09-02

2.  Imaging Lung Function Abnormalities in Primary Ciliary Dyskinesia Using Hyperpolarized Gas Ventilation MRI.

Authors:  Laurie J Smith; Noreen West; David Hughes; Helen Marshall; Christopher S Johns; Neil J Stewart; Ho-Fung Chan; Madhwesha Rao; David J Capener; Jody Bray; Guilhem J Collier; Paul J C Hughes; Graham Norquay; Lynne Schofield; Phil Chetcuti; Eduardo Moya; Jim M Wild
Journal:  Ann Am Thorac Soc       Date:  2018-12

3.  The Primary Ciliary Dyskinesia Computed Tomography Score in Adults with Bronchiectasis: A Derivation und Validation Study.

Authors:  Jessica Rademacher; Sabine Dettmer; Jan Fuge; Jens Vogel-Claussen; Hoen-Oh Shin; Anand Shah; Paula Inês Pedro; Rob Wilson; Tobias Welte; Frank Wacker; Michael R Loebinger; Felix C Ringshausen
Journal:  Respiration       Date:  2021-04-23       Impact factor: 3.580

4.  Clinical and Genetic Spectrum of Children With Primary Ciliary Dyskinesia in China.

Authors:  Yuhong Guan; Haiming Yang; Xingfeng Yao; Hui Xu; Hui Liu; Xiaolei Tang; Chanjuan Hao; Xiang Zhang; Shunying Zhao; Wentong Ge; Xin Ni
Journal:  Chest       Date:  2021-02-10       Impact factor: 9.410

5.  Biallelic DNAH9 mutations are identified in Chinese patients with defective left-right patterning and cilia-related complex congenital heart disease.

Authors:  Weicheng Chen; Yuan Zhang; Libing Shen; Jialiang Zhu; Ke Cai; Zhouping Lu; Weijia Zeng; Jianyuan Zhao; Xiangyu Zhou
Journal:  Hum Genet       Date:  2022-01-20       Impact factor: 5.881

6.  Whole-Exome Sequencing Identified a Novel Compound Heterozygous Mutation of LRRC6 in a Chinese Primary Ciliary Dyskinesia Patient.

Authors:  Lv Liu; Hong Luo
Journal:  Biomed Res Int       Date:  2018-01-08       Impact factor: 3.411

7.  Corrigendum: Compound Heterozygous Variants in the Coiled-Coil Domain Containing 40 Gene in a Chinese Family With Primary Ciliary Dyskinesia Cause Extreme Phenotypic Diversity in Cilia Ultrastructure.

Authors:  Lin Yang; Santasree Banerjee; Jie Cao; Xiaohong Bai; Zhijun Peng; Haixia Chen; Hui Huang; Peng Han; Shunyu Feng; Na Yi; Xueru Song; Jing Wu
Journal:  Front Genet       Date:  2018-04-04       Impact factor: 4.599

Review 8.  Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis.

Authors:  Jürgen Schäfer; Matthias Griese; Ravishankar Chandrasekaran; Sanjay H Chotirmall; Dominik Hartl
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

9.  Compound Heterozygous Variants in the Coiled-Coil Domain Containing 40 Gene in a Chinese Family with Primary Ciliary Dyskinesia Cause Extreme Phenotypic Diversity in Cilia Ultrastructure.

Authors:  Lin Yang; Santasree Banerjee; Jie Cao; Xiaohong Bai; Zhijun Peng; Haixia Chen; Hui Huang; Peng Han; Shunyu Feng; Na Yi; Xueru Song; Jing Wu
Journal:  Front Genet       Date:  2018-02-02       Impact factor: 4.599

10.  Genomic profiling supports the diagnosis of primary ciliary dyskinesia and reveals novel candidate genes and genetic variants.

Authors:  Marina Andjelkovic; Predrag Minic; Misa Vreca; Maja Stojiljkovic; Anita Skakic; Aleksandar Sovtic; Milan Rodic; Vesna Skodric-Trifunovic; Nina Maric; Jelena Visekruna; Vesna Spasovski; Sonja Pavlovic
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.